Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 2461 to 2475 of 8785 results

  1. Technologies to improve the detection of endometrial cancer

    Topic prioritisation

  2. Eptinezumab for preventing cluster headache attacks TSID 12087

    Topic prioritisation

  3. Sumatriptan–naproxen for treating migraine-related moderate to severe headache [TS ID 12055]

    Topic prioritisation

  4. Entrectinib for treating NTRK fusion-positive solid tumours in people 1 month to 11 years [TSID12116]

    Topic prioritisation

  5. Henlius (pertuzumab biosimilar) for treating HER2-positive breast cancer [TS ID 12094]

    Topic prioritisation

  6. Remimazolam for sedation for people having diagnostic or therapeutic procedures [ID3758]

    Topic prioritisation

  7. Magtrace/Sentimag MT599 (MIB263)

    Topic prioritisation

  8. Pitolisant for treating narcolepsy in children and young people 6 to 17 years ID6353

    Topic prioritisation

  9. Ceftobiprole medocaril for treating community- or hospital-acquired pneumonia in people 3 months to 17 years [TSID11819]

    Topic prioritisation

  10. Subcutaneous ocrelizumab for treating primary progressive or relapsing multiple sclerosis [TSID11895]

    Topic prioritisation

  11. Natalizumab for treating highly active relapsing-remitting multiple sclerosis [ID4020]

    Topic prioritisation

  12. Remimazolam for general anaesthesia [ID3796]

    Topic prioritisation

  13. Neonatal infection: antibiotics for prevention and treatment - update

    In development Reference number: GID-NG10456 Expected publication date:  13 May 2026

  14. Epilepsies in children, young people and adults

    In development Reference number: GID-NG10453 Expected publication date: TBC

  15. Lutetium-177 vipivotide tetraxetan in combination for treating PSMA-positive hormone-sensitive metastatic prostate cancer [ID6589]

    In development Reference number: GID-TA11766 Expected publication date: TBC